Tuesday, 23 August 2016

Pfizer to buy biotech company Medivation in £11bn deal



PFIZER gave its growing oncology operation a shot in the arm as it beat competition from rival suitors to land Californian biotech company Medivation in a $14billion deal.

No comments:

Post a Comment